Flesinoxan hydrochloride -: Anxiolytic antidepressant

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：72 / 73
页数：2
相关论文
共 50 条
  • [21] ANALYSIS OF ANXIOLYTIC AND ANTIDEPRESSANT DRUG EFFECTS IN THE PIGEON
    BARRETT, JE
    PSYCHOPHARMACOLOGY, 1990, 101 : S5 - S5
  • [22] TIANEPTINE - NO-SEDATIVE ANXIOLYTIC ANTIDEPRESSANT - INTRODUCTION
    KAMOUN, A
    PRESSE MEDICALE, 1991, 20 (37): : 1799 - 1800
  • [23] The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
    Radosavljevic, Milica
    Svob Strac, Dubravka
    Jancic, Jasna
    Samardzic, Janko
    GENES, 2023, 14 (05)
  • [24] BEHAVIORAL PHARMACOLOGY: POTENTIAL ANTIDEPRESSANT AND ANXIOLYTIC PROPERTIES
    Wesolowska, Anna
    Jastrzebska-Wiesek, Magdalena
    PHARMACOLOGY OF 5-HT6 RECEPTORS, PT II, 2011, 96 : 49 - 71
  • [25] RECENT DEVELOPMENTS IN THE USE OF ANTIDEPRESSANT AND ANXIOLYTIC MEDICATIONS
    SIMEON, JG
    FERGUSON, HB
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1985, 8 (04) : 893 - 907
  • [26] TRIMIPRAMINE AND MAPROTILINE - ANTIDEPRESSANT, ANXIOLYTIC, AND CARDIOTOXIC COMPARISON
    PECKNOLD, JC
    FAMILAMIRI, P
    MCCLURE, DJ
    ELIE, R
    CHANG, H
    JOURNAL OF CLINICAL PSYCHIATRY, 1985, 46 (05) : 166 - 171
  • [27] Neural circuits of anxiolytic and antidepressant pherine molecules
    Monti, Louis
    Liebowitz, Michael R.
    CNS SPECTRUMS, 2022, 27 (01) : 66 - 72
  • [28] EVALUATION OF THE ANXIOLYTIC AND ANTIDEPRESSANT ACTIVITIES OF AUCUBIN IN MICE
    Chu, Hongbiao
    Li, Rui
    Gao, Yan
    Li, Qingyao
    ACTA POLONIAE PHARMACEUTICA, 2020, 77 (05): : 793 - 803
  • [29] A NEW ANTIDEPRESSANT OF TRICYCLIC GROUP - NORTRIPTYLINE HYDROCHLORIDE (AVENTYL HYDROCHLORIDE)
    不详
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 194 (07): : 727 - &
  • [30] THE ANXIOLYTIC EFFECTS OF FLESINOXAN, A 5-HT1A RECEPTOR AGONIST, ARE NOT RELATED TO ITS NEUROENDOCRINE EFFECTS
    GROENINK, L
    VANDERGUGTEN, J
    VERDOUW, PM
    MAES, RAA
    OLIVIER, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 280 (02) : 185 - 193
12345